AVBP Stock Analysis: Buy, Sell, or Hold?

AVBP - ArriVent BioPharma, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$29.12
-0.06 (-0.21%) ▼
5d: -1.32%
30d: -7.67%
90d: +7.85%
HOLD
MODERATE Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 10, 2026 0d

Get Alerted When AVBP Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: AVBP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: AVBP is currently trading at $29.12, which is considered oversold relative to its 30-day fair value range of $29.25 to $31.75.

Technical Outlook: Technically, AVBP is in a uptrend. The price is currently testing key support at $28.57. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: AVBP scores 37/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (29th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $44.70 (+53.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $29.25 - $31.75
Company Quality Score 58/100 (HOLD)
Options IV Signal 29th percentile (LOW)
Volume Confirmation HIGH
Confidence Score 66.7%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 29th percentile)
  • BEARISH: Weak technical setup (37/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 53.5% below Wall St target ($44.70)

Trading Range Analysis

30-Day Trading Range $29.25 - $31.75
Current vs Trading Range OVERSOLD
Expected Move (7 Days) ±$5.17 (17.8%)

Support & Resistance Levels

Support Level $28.57
Resistance Level $31.60
Current Trend Uptrend
Technical data as of Aug 21, 2026

Fundamental Context

Forward P/E (Next Year Est.) -7.42
Wall Street Target $44.70 (+53.5%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 23, 2026 12:04 PM ET
Data refreshes hourly during market hours. Next update: 1:04 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for AVBP.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ARGX
argenx NV ADR
STRONG BUY
22 analysts
$1173 43 HOLD
LEGN
Legend Biotech Corp
STRONG BUY
22 analysts
$49 39 SELL
SRPT
Sarepta Therapeutics Inc
STRONG BUY
26 analysts
$22 26 SELL
MRUS
Merus BV
STRONG BUY
17 analysts
$97 39 SELL
KYMR
Kymera Therapeutics Inc
STRONG BUY
20 analysts
$131 38 SELL

More Analysis for AVBP

AVBP Technical Chart AVBP Price Prediction AVBP Earnings Date AVBP Investment Advisor AVBP Fair Price Analyzer AVBP Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals